Dystonia-plus syndromes.

Area of Science:

• Neurology
• Genetics
• Neurodegenerative Diseases

Background:

• Dystonia-plus syndromes are a heterogeneous group of neurological disorders.
• These syndromes are characterized by the presence of dystonia alongside other neurological features.
• Genetic mutations are frequently identified as causative factors in these conditions.

Purpose of the Study:

• To delineate the classification and genetic underpinnings of dystonia-plus syndromes.
• To differentiate dystonia-plus syndromes from symptomatic dystonias and complex neurodegenerative diseases.
• To provide an overview of the diagnostic approaches and genetic mutations associated with specific dystonia-plus syndromes.

Main Methods:

• Review and synthesis of existing literature on dystonia-plus syndromes.
• Analysis of clinical presentations and inheritance patterns.
• Identification of associated gene mutations and diagnostic markers.

Main Results:

• Dopa-responsive dystonia (DRD) is classified into autosomal-dominant (GCH1 mutations) and autosomal-recessive forms (TH, SPR mutations), with varying severity.
• Myoclonus-dystonia (M-D) is linked to SGCE mutations, presenting with mild-to-moderate dystonia and myoclonus, typically with onset before 25 years.
• Rapid-onset dystonia-parkinsonism (RPD, DYT12) associated with ATP1A3 mutations and a novel form (DYT16) linked to PRKRA mutations are described.

Conclusions:

• Dystonia-plus syndromes encompass distinct genetic disorders with specific clinical and etiological profiles.
• Accurate diagnosis relies on a combination of clinical evaluation, biochemical analyses (e.g., CSF pterine metabolites), and comprehensive genetic testing.
• Understanding the genetic basis of these syndromes is crucial for targeted diagnosis and potential therapeutic strategies.